World Leading NHS Ecig Trial
The University of East Anglia and the NHS are joining up to run an e-cig trial project described as a “landmark moment for vaping and harm reduction”
-
by Dave Cross
Share on:
Patients taking part in the trial will be split into groups. The first will receive a starter kit and support, the rest will receive advice and leaflets on how to quit. Success will be measured with follow-ups over a 30-month period to see how many managed to quit smoking and remain smoke-free.
The Independent British Vape Trade Association (IBVTA) (1) said: “The importance of this announcement cannot be overstated. For the first time ever, one of the world’s most respected health institutions, the NHS, will be directly involved in delivering vaping to smokers as a means to quit.”
The UK Vaping Industry Association (UKVIA) (2) described the announcement as a “landmark moment”.
“For years,” it continued, “the UKVIA has campaigned for vaping to be recognised as the best and most effective method for reducing smoking, with health protection organisations including Public Health England and Cancer Research UK all backing e-cigarettes’ use in cessation services.”
UKVIA pointed out the trial, which is being funded by the National Institute for Health Research, comes as shocking new data released by Mintel showed that 39% of smokers aged 18-34 said they were now smoking more regularly due to stress from Covid-19. It also revealed that 10% of former smokers had restarted their habit since the start of the pandemic. In addition, according to experts Emergency Departments see over 24m people each year of whom around a quarter are current smokers.
The IBVTA highlights that the positive news comes at a time when only two in five smokers in Great Britain can correctly identify that vaping is less harmful than smoking. This number has fallen consistently over the last few years due to several misleading news stories that were clearly understood by experts to be fallacious, but where public opinion was never adequately rebalanced.
Gillian Golden, IBVTA Chief Executive, roundly endorsed the launch of the study: “As an advocate of vaping for quitting smoking of many years, I am thrilled to see the launch of this trial. I have the privilege of representing a number of businesses, all completely independent of the tobacco industry, that have been instrumental in making the UK a world leader in the vape sector, specifically in driving down smoking rates through vaping. This trial, and the involvement of the NIHR and the NHS, is a huge affirmation that our members’ tireless work over many years has been and is worthwhile.”
John Dunne, Director General of the UKVIA, commented: “This is a hugely significant moment in the history of vaping and harm reduction. For the first time, following years of research and campaigning, we are finally at the point where the NHS looks to be fully embracing vaping and acknowledging its important role as the number one quit method.
“This move by a respected and trusted institution worldwide proves that all the misinformation out there on vaping, is as we have been saying for years misinformation itself. It reinforces Public Health England’s recent annual vaping evidence review that perceptions of harm caused by vaping compared with smoking are increasingly out of line with evidence.”
Sir Norman Lamb, former Health Minister & former Chair of the House of Commons Science and Technology Committee has said: “As a former Health Minister and a former smoker I welcome this trial being launched and the additional research, which will hopefully make it easier for people to quit smoking in the future. I am particularly keen to ensure that vaping is made available to people with mental ill health given continuing high smoking rates. It is very positive to have such a prominent trial funded by the National Institute for Health Research (NIHR) including clinical trials. I await the results with interest.”
References:
- The Independent British Vape Trade Association – https://www.ibvta.org.uk/
- The UK Vaping Industry Association – https://www.ukvia.co.uk/
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous start-ups to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
CAPHRA Highlights Tobacco Control Flaws
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates highlights the flaws in tobacco control which has led to the rise of black market in Australia
-
by Dave Cross
A Missed Opportunity at COP10
The Smoke Free Sweden movement says that COP10 was a missed opportunity to save millions of lives
-
by Dave Cross
COP10: Promote Tobacco Harm Reduction
Experts with Smoke Free Sweden are emphasising the urgent need for a Tobacco Harm Reduction approach at COP10
-
by Dave Cross
